Hepatitis C Compensation Tribunal (Amendment) Act, 2002
|
Interpretation. |
1.—(1) In this Act, unless the context otherwise requires— | |
“HIV” means human immunodeficiency virus; | ||
“the Principal Act” means the Hepatitis C Compensation Tribunal Act, 1997 ; | ||
“relevant product” means a blood product or a blood component used to treat persons with haemophilia or other blood clotting disorders in respect of those conditions; | ||
“the 1991 settlement” means the agreement made in 1991 in settlement of proceedings against the State and other parties relating to the infection with HIV of certain persons as a result of those persons receiving blood or blood products in the State; | ||
“the Tribunal” means the Tribunal established by section 3 of the Principal Act and known, by virtue of section 2 , as the Hepatitis C and HIV Compensation Tribunal. | ||
(2) In this Act— | ||
(a) a reference to a section is a reference to a section of this Act, unless it is indicated that reference to some other provision is intended, | ||
(b) a reference to a subsection, paragraph or subparagraph is a reference to a subsection, paragraph or subparagraph of the provision in which the reference occurs, unless it is indicated that reference to some other provision is intended, and | ||
(c) a reference to any enactment is a reference to that enactment as amended, adapted or extended by or under any subsequent enactment. |